vs
OIL STATES INTERNATIONAL, INC（OIS）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是OIL STATES INTERNATIONAL, INC的1.2倍（$207.3M vs $178.5M），Ultragenyx Pharmaceutical Inc.净利率更高（-62.0% vs -65.7%，领先3.7%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 8.4%），OIL STATES INTERNATIONAL, INC自由现金流更多（$47.1M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 3.3%）
石油国家国际公司是一家美国跨国企业，核心业务是为油气行业企业提供专业相关服务，目前是在纽约证券交易所上市的公众公司。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
OIS vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $178.5M | $207.3M |
| 净利润 | $-117.2M | $-128.6M |
| 毛利率 | 10.9% | — |
| 营业利润率 | -63.7% | -54.7% |
| 净利率 | -65.7% | -62.0% |
| 营收同比 | 8.4% | 25.9% |
| 净利润同比 | -873.2% | 3.5% |
| 每股收益（稀释后） | $-1.99 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $178.5M | $207.3M | ||
| Q3 25 | $165.2M | $159.9M | ||
| Q2 25 | $165.4M | $166.5M | ||
| Q1 25 | $159.9M | $139.3M | ||
| Q4 24 | $164.6M | $164.6M | ||
| Q3 24 | $174.3M | $139.5M | ||
| Q2 24 | $186.4M | $147.0M | ||
| Q1 24 | $167.3M | $108.8M |
| Q4 25 | $-117.2M | $-128.6M | ||
| Q3 25 | $1.9M | $-180.4M | ||
| Q2 25 | $2.8M | $-115.0M | ||
| Q1 25 | $3.2M | $-151.1M | ||
| Q4 24 | $15.2M | $-133.2M | ||
| Q3 24 | $-14.3M | $-133.5M | ||
| Q2 24 | $1.3M | $-131.6M | ||
| Q1 24 | $-13.4M | $-170.7M |
| Q4 25 | 10.9% | — | ||
| Q3 25 | 22.1% | — | ||
| Q2 25 | 24.2% | — | ||
| Q1 25 | 23.3% | — | ||
| Q4 24 | 23.7% | — | ||
| Q3 24 | 21.7% | — | ||
| Q2 24 | 23.8% | — | ||
| Q1 24 | 21.1% | — |
| Q4 25 | -63.7% | -54.7% | ||
| Q3 25 | 2.9% | -106.9% | ||
| Q2 25 | 3.2% | -64.8% | ||
| Q1 25 | 3.5% | -102.6% | ||
| Q4 24 | 11.2% | -74.3% | ||
| Q3 24 | -6.3% | -94.6% | ||
| Q2 24 | 1.1% | -79.1% | ||
| Q1 24 | -6.7% | -151.9% |
| Q4 25 | -65.7% | -62.0% | ||
| Q3 25 | 1.2% | -112.8% | ||
| Q2 25 | 1.7% | -69.0% | ||
| Q1 25 | 2.0% | -108.5% | ||
| Q4 24 | 9.2% | -80.9% | ||
| Q3 24 | -8.2% | -95.7% | ||
| Q2 24 | 0.7% | -89.5% | ||
| Q1 24 | -8.0% | -156.8% |
| Q4 25 | $-1.99 | $-1.28 | ||
| Q3 25 | $0.03 | $-1.81 | ||
| Q2 25 | $0.05 | $-1.17 | ||
| Q1 25 | $0.05 | $-1.57 | ||
| Q4 24 | $0.24 | $-1.34 | ||
| Q3 24 | $-0.23 | $-1.40 | ||
| Q2 24 | $0.02 | $-1.52 | ||
| Q1 24 | $-0.21 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $69.9M | $421.0M |
| 总债务越低越好 | $1.7M | — |
| 股东权益账面价值 | $573.2M | $-80.0M |
| 总资产 | $883.4M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
| Q4 25 | $69.9M | $421.0M | ||
| Q3 25 | $67.1M | $202.5M | ||
| Q2 25 | $53.9M | $176.3M | ||
| Q1 25 | $66.8M | $127.1M | ||
| Q4 24 | $65.4M | $174.0M | ||
| Q3 24 | $46.0M | $150.6M | ||
| Q2 24 | $25.2M | $480.7M | ||
| Q1 24 | $24.1M | $112.3M |
| Q4 25 | $1.7M | — | ||
| Q3 25 | $1.9M | — | ||
| Q2 25 | $1.9M | — | ||
| Q1 25 | $124.7M | — | ||
| Q4 24 | $124.7M | — | ||
| Q3 24 | $124.6M | — | ||
| Q2 24 | $124.3M | — | ||
| Q1 24 | $135.6M | — |
| Q4 25 | $573.2M | $-80.0M | ||
| Q3 25 | $689.0M | $9.2M | ||
| Q2 25 | $690.6M | $151.3M | ||
| Q1 25 | $683.4M | $144.2M | ||
| Q4 24 | $680.7M | $255.0M | ||
| Q3 24 | $684.8M | $346.8M | ||
| Q2 24 | $690.4M | $432.4M | ||
| Q1 24 | $692.3M | $140.3M |
| Q4 25 | $883.4M | $1.5B | ||
| Q3 25 | $1.0B | $1.2B | ||
| Q2 25 | $993.7M | $1.3B | ||
| Q1 25 | $990.7M | $1.3B | ||
| Q4 24 | $1.0B | $1.5B | ||
| Q3 24 | $994.1M | $1.5B | ||
| Q2 24 | $1.0B | $1.6B | ||
| Q1 24 | $1.0B | $1.3B |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.18× | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | 0.18× | — | ||
| Q2 24 | 0.18× | — | ||
| Q1 24 | 0.20× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $50.1M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $47.1M | $-100.8M |
| 自由现金流率自由现金流/营收 | 26.4% | -48.6% |
| 资本支出强度资本支出/营收 | 1.7% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $73.9M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $50.1M | $-99.8M | ||
| Q3 25 | $30.7M | $-91.4M | ||
| Q2 25 | $15.0M | $-108.3M | ||
| Q1 25 | $9.3M | $-166.5M | ||
| Q4 24 | $18.2M | $-79.3M | ||
| Q3 24 | $28.8M | $-67.0M | ||
| Q2 24 | $10.2M | $-77.0M | ||
| Q1 24 | $-11.4M | $-190.7M |
| Q4 25 | $47.1M | $-100.8M | ||
| Q3 25 | $22.0M | $-92.7M | ||
| Q2 25 | $4.7M | $-110.7M | ||
| Q1 25 | $137.0K | $-167.8M | ||
| Q4 24 | $4.0M | $-79.5M | ||
| Q3 24 | $21.4M | $-68.6M | ||
| Q2 24 | $4.5M | $-79.0M | ||
| Q1 24 | $-21.5M | $-193.9M |
| Q4 25 | 26.4% | -48.6% | ||
| Q3 25 | 13.3% | -58.0% | ||
| Q2 25 | 2.8% | -66.5% | ||
| Q1 25 | 0.1% | -120.5% | ||
| Q4 24 | 2.4% | -48.3% | ||
| Q3 24 | 12.3% | -49.2% | ||
| Q2 24 | 2.4% | -53.7% | ||
| Q1 24 | -12.8% | -178.2% |
| Q4 25 | 1.7% | 0.5% | ||
| Q3 25 | 5.3% | 0.8% | ||
| Q2 25 | 6.2% | 1.5% | ||
| Q1 25 | 5.7% | 1.0% | ||
| Q4 24 | 8.6% | 0.1% | ||
| Q3 24 | 4.3% | 1.2% | ||
| Q2 24 | 3.1% | 1.4% | ||
| Q1 24 | 6.0% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | 16.15× | — | ||
| Q2 25 | 5.33× | — | ||
| Q1 25 | 2.94× | — | ||
| Q4 24 | 1.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 7.87× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OIS
| Project Driven | $112.6M | 63% |
| Downhole Technologies | $32.1M | 18% |
| Completion And Production Services | $23.1M | 13% |
| Military And Other Products | $10.7M | 6% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
